Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PASIREOTIDE DIASPARTATE: 283 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
283
Total FAERS Reports
18 (6.4%)
Deaths Reported
67
Hospitalizations
283
As Primary/Secondary Suspect
7
Life-Threatening
2
Disabilities
Dec 14, 2012
FDA Approved
Prescription
Status

FDA Application: 200677 ·

Patent Expires: Dec 14, 2026 · First Report: 20130328 · Latest Report: 20250912

What Are the Most Common PASIREOTIDE DIASPARTATE Side Effects?

#1 Most Reported
Nausea
66 reports (23.3%)
#2 Most Reported
Off label use
42 reports (14.8%)
#3 Most Reported
Fatigue
40 reports (14.1%)

All PASIREOTIDE DIASPARTATE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Nausea 66 23.3% 1 16
Off label use 42 14.8% 3 9
Fatigue 40 14.1% 0 11
Diarrhoea 38 13.4% 2 9
Blood glucose increased 36 12.7% 1 7
Diabetes mellitus 35 12.4% 0 4
Dizziness 34 12.0% 0 5
Vomiting 34 12.0% 0 12
Headache 33 11.7% 1 8
Hyperglycaemia 20 7.1% 0 5
Hypoglycaemia 19 6.7% 0 7
Abdominal pain 18 6.4% 0 7
Asthenia 17 6.0% 0 7
Blood glucose decreased 16 5.7% 0 4
Blood pressure increased 16 5.7% 0 5
Abdominal pain upper 15 5.3% 0 1
Malaise 15 5.3% 0 7
Somnolence 14 5.0% 1 0
Weight decreased 14 5.0% 1 1
Weight increased 14 5.0% 0 0

Who Reports PASIREOTIDE DIASPARTATE Side Effects? Age & Gender Data

Gender: 73.1% female, 26.9% male. Average age: 49.4 years. Most reports from: US. View detailed demographics →

Is PASIREOTIDE DIASPARTATE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2013 2 0 1
2014 6 1 2
2015 7 0 3
2016 11 0 5
2017 11 0 2
2018 15 0 2
2019 10 0 5
2020 34 2 9
2021 26 4 10
2022 27 4 8
2023 25 1 9
2024 13 0 0
2025 15 3 5

View full timeline →

What Is PASIREOTIDE DIASPARTATE Used For?

IndicationReports
Pituitary-dependent cushing's syndrome 146
Product used for unknown indication 38
Cushing's syndrome 32
Acromegaly 22
Hypoglycaemia 20
Off label use 17

PASIREOTIDE DIASPARTATE vs Alternatives: Which Is Safer?

PASIREOTIDE DIASPARTATE vs PATIROMER PASIREOTIDE DIASPARTATE vs PATISIRAN PASIREOTIDE DIASPARTATE vs PAXIL PASIREOTIDE DIASPARTATE vs PAZOPANIB PASIREOTIDE DIASPARTATE vs PEANUT PASIREOTIDE DIASPARTATE vs PEG INTERFERON PASIREOTIDE DIASPARTATE vs PEG-INTERFERON ALFA 2A PASIREOTIDE DIASPARTATE vs PEGASPARGASE PASIREOTIDE DIASPARTATE vs PEGASYS PASIREOTIDE DIASPARTATE vs PEGCETACOPLAN

Official FDA Label for PASIREOTIDE DIASPARTATE

Official prescribing information from the FDA-approved drug label.